Literature DB >> 16557795

Antibody responses in serum, secretions, and urine of man after parenteral administration of vaccines.

S Sirisinha1, C Charupatana.   

Abstract

The nature of antibody activities associated with purified immunoglobulin fractions of serum, secretions (whole saliva, parotid secretion, and intestinal secretion), and urine of a volunteer after subcutaneous booster injections with rabies virus, poliovirus, diphtheria and tetanus toxoids, and typhoid-paratyphoid-cholera vaccines was investigated. The results showed that the pattern of antibody responses in these fluids differed from one antigen to another. Serum-antibody responses to killed-bacterial vaccine were associated mainly with the immunoglobulin M (IgM) component, slight activities were detected in the IgG, and only traces of activities, if any, were found in the IgA. These antibodies were primarily of the secretory IgA type in whole saliva and parotid secretion. Slight activities were also observed in the urinary IgG fraction. Responses to inactivated viral vaccine and toxoids were almost exclusively associated with the serum IgG component. Some antitoxic activities to diphtheria and tetanus toxins were noted in a low-molecular-weight urinary immunoglobulin component.

Entities:  

Year:  1970        PMID: 16557795      PMCID: PMC415959          DOI: 10.1128/iai.2.1.29-37.1970

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  The properties of isolated serum and urinary antibodies to a single antigen.

Authors:  E Merler
Journal:  Immunology       Date:  1966-03       Impact factor: 7.397

2.  Antibodies of IgA and IgG class in normal human urine.

Authors:  M W Turner; D S Rowe
Journal:  Immunology       Date:  1967-06       Impact factor: 7.397

3.  Immunoglobulins in serum and nasal secretions following infection with type 1 parainfluenza virus and injection of inactivated vaccines.

Authors:  C B Smith; J A Bellanti; R M Chanock
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

4.  Natural antibodies of human serum, saliva, and urine reactive with Escherichia coli.

Authors:  D Tourville; J Bienenstock; T B Tomasi
Journal:  Proc Soc Exp Biol Med       Date:  1968-07

5.  Immunoglobulins in human small intestinal fluid.

Authors:  A G Plaut; P Keonil
Journal:  Gastroenterology       Date:  1969-03       Impact factor: 22.682

6.  Neutralization of poliovirus by IgA coproantibodies.

Authors:  R Keller; J E Dwyer
Journal:  J Immunol       Date:  1968-08       Impact factor: 5.422

Review 7.  Secretory immunoglobulins.

Authors:  T B Tomasi; J Bienenstock
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

8.  Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.

Authors:  J A Bellanti; R L Sanga; B Klutinis; B Brandt; M S Artenstein
Journal:  N Engl J Med       Date:  1969-03-20       Impact factor: 91.245

9.  Intestinal IgA neutralizing antibodies in newborn infants following poliovirus immunization.

Authors:  R Keller; J E Dwyer; W Oh; M D'Amodio
Journal:  Pediatrics       Date:  1969-03       Impact factor: 7.124

10.  Secretory gamma-A antibodies induced by local immunization.

Authors:  R J Genco; M A Taubman
Journal:  Nature       Date:  1969-02-15       Impact factor: 49.962

View more
  2 in total

1.  Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 serotype Ogawa with emphasis on antigenic density and chain length.

Authors:  Peter Ftacek; Victor Nelson; Shousun C Szu
Journal:  Glycoconj J       Date:  2013-08-17       Impact factor: 2.916

2.  Scalable production and immunogenicity of a cholera conjugate vaccine.

Authors:  Suhi Jeon; Meagan Kelly; Jeesun Yun; Byungman Lee; Minchul Park; Yoonhee Whang; Chankyu Lee; Yuan-Di Halvorsen; Smriti Verma; Richelle C Charles; Jason B Harris; Stephen B Calderwood; Daniel T Leung; Taufiqur R Bhuiyan; Firdausi Qadri; Mohammad Kamruzzaman; Somyoung Cho; Willie F Vann; Peng Xu; Pavol Kováč; Ravi Ganapathy; Julia Lynch; Edward T Ryan
Journal:  Vaccine       Date:  2021-10-27       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.